Analgesic nephropathy historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (11 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Analgesic nephropathy}} | {{Analgesic nephropathy}} | ||
{{CMG}} | {{CMG}} {{AE}} {{SHA}} | ||
{{ | |||
== Overview == | == Overview == | ||
In 1953, the association between analgesic drugs and chronic renal disease was first reported in German. In 1977, Australia was first to legally ban [[phenacetin]]. In 1983, [[phenacetin]] was withdrawn from the US markets. | |||
== Historical Perspective == | == Historical Perspective == | ||
* In 1887, phenacetin was introduced as an analgesic | * In 1887, [[phenacetin]] was introduced as an analgesic which later became know that is metabolized to [[acetaminophen]].<ref name="Foye 2008 p.">{{cite book | last=Foye | first=William | title=Foye's principles of medicinal chemistry | publisher=Lippincott Williams & Wilkins | publication-place=Philadelphia | year=2008 | isbn=978-0-7817-6879-5 | oclc=145942325 | page=}}</ref> | ||
* In 1893, | * In 1893, [[acetaminophen]] was introduced as an analgesic.<ref name="Foye 2008 p.">{{cite book | last=Foye | first=William | title=Foye's principles of medicinal chemistry | publisher=Lippincott Williams & Wilkins | publication-place=Philadelphia | year=2008 | isbn=978-0-7817-6879-5 | oclc=145942325 | page=}}</ref> | ||
* In 1953, the association between analgesic drugs and chronic renal disease was first reported in German.<ref name="pmid13137299">{{cite journal |author=Spühler O, Zollinger HU |title=Die chronisch-interstitielle Nephritis. |language=German |journal=Z Klin Med |volume=151 |issue=1 |pages=1–50 |year=1953 |pmid=13137299 |doi= |url=}}</ref> | * In 1953, the association between [[Analgesic|analgesic drugs]] and [[Chronic renal failure|chronic renal disease]] was first reported in German.<ref name="pmid13137299">{{cite journal |author=Spühler O, Zollinger HU |title=Die chronisch-interstitielle Nephritis. |language=German |journal=Z Klin Med |volume=151 |issue=1 |pages=1–50 |year=1953 |pmid=13137299 |doi= |url=}}</ref> | ||
* In | * In 1977, [[phenacetin]] became legally banned in Australia.<ref name="pmid11181803">{{cite journal |author=Michielsen P, de Schepper P |title=Trends of analgesic nephropathy in two high-endemic regions with different legislation |journal=J. Am. Soc. Nephrol. |volume=12 |issue=3 |pages=550–6 |year=2001 |month=March |pmid=11181803 |doi= |url=http://jasn.asnjournals.org/cgi/pmidlookup?view=long&pmid=11181803}}</ref> | ||
* In 1978, [[phenacetin]] was withdrawn from the Canadian markets.<ref name="pmid6937434">{{cite journal| author=| title=Some pharmaceutical drugs. | journal=IARC Monogr Eval Carcinog Risk Chem Hum | year= 1980 | volume= 24 | issue= | pages= 1-337 | pmid=6937434 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6937434 }} </ref> | |||
*In 1980, [[phenacetin]] was withdrawn from the markets in the United Kingdom.<ref name="pmid6937434">{{cite journal| author=| title=Some pharmaceutical drugs. | journal=IARC Monogr Eval Carcinog Risk Chem Hum | year= 1980 | volume= 24 | issue= | pages= 1-337 | pmid=6937434 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6937434 }} </ref> | |||
* In 1983, [[phenacetin]] was withdrawn from the US markets.<ref name="pmid10557618">{{cite journal| author=| title=List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness. Food and Drug Administration, HHS. Final rule. | journal=Fed Regist | year= 1999 | volume= 64 | issue= 44 | pages= 10944-7 | pmid=10557618 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10557618 }} </ref> | |||
==References== | ==References== | ||
Latest revision as of 06:12, 8 July 2020
|
Analgesic nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Analgesic nephropathy historical perspective On the Web |
|
American Roentgen Ray Society Images of Analgesic nephropathy historical perspective |
|
Risk calculators and risk factors for Analgesic nephropathy historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
In 1953, the association between analgesic drugs and chronic renal disease was first reported in German. In 1977, Australia was first to legally ban phenacetin. In 1983, phenacetin was withdrawn from the US markets.
Historical Perspective
- In 1887, phenacetin was introduced as an analgesic which later became know that is metabolized to acetaminophen.[1]
- In 1893, acetaminophen was introduced as an analgesic.[1]
- In 1953, the association between analgesic drugs and chronic renal disease was first reported in German.[2]
- In 1977, phenacetin became legally banned in Australia.[3]
- In 1978, phenacetin was withdrawn from the Canadian markets.[4]
- In 1980, phenacetin was withdrawn from the markets in the United Kingdom.[4]
- In 1983, phenacetin was withdrawn from the US markets.[5]
References
- ↑ 1.0 1.1 Foye, William (2008). Foye's principles of medicinal chemistry. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0-7817-6879-5. OCLC 145942325.
- ↑ Spühler O, Zollinger HU (1953). "Die chronisch-interstitielle Nephritis". Z Klin Med (in German). 151 (1): 1–50. PMID 13137299.
- ↑ Michielsen P, de Schepper P (2001). "Trends of analgesic nephropathy in two high-endemic regions with different legislation". J. Am. Soc. Nephrol. 12 (3): 550–6. PMID 11181803. Unknown parameter
|month=ignored (help) - ↑ 4.0 4.1 "Some pharmaceutical drugs". IARC Monogr Eval Carcinog Risk Chem Hum. 24: 1–337. 1980. PMID 6937434.
- ↑ "List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness. Food and Drug Administration, HHS. Final rule". Fed Regist. 64 (44): 10944–7. 1999. PMID 10557618.